SECTION I:

FOUNDATIONS OF PSYCHOPHARMACOLOGY

• Origins of Psychotropic Drug Development

• Paradigm Shifts in Psychiatric Treatment

• From Serendipity to Rational Drug Design

• Principles of Pharmacokinetics & Pharmacodynamics

• Agonism, Antagonism, and Partial Agonism

• Receptor Theory and Signal Transduction

• Neurotransmitters**: Two sides of the coin

• Classification of Psychotropics : pros and cons

SECTION II:

PSYCHOPHARMACOLOGY OF MAJOR PSYCHIATRIC DISORDERS

Antipsychotic Drugs

• Typical and Atypical Antipsychotics (Each Drug in detail)

• Mechanisms of Action and Clinical Efficacy

• Adverse Effects

• Clinical Pearls

• Precise selection of antipsychotic agents in different scenarios (Real Case Scenarios)

Antidepressant Drugs

• All classes of antidepressants (Each Drug in detail)

• Novel antidepressants and Rapid-acting antidepressants (Ketamine & others)

• Mechanisms of Action and Clinical Efficacy

• Adverse Effects & Clinical Pearls

• Precise selection of antidepressant agents in different scenarios (Real Case Scenarios)

Mood Stabilizers

• All Mood Stabilizers (Each Drug in detail)

• Mechanisms of Action and Clinical Efficacy

• Adverse Effects

• Clinical Pearls

• Precise selection of mood stabilizers agents in different scenarios (Real Case Scenarios)

Anxiolytics and Hypnotics

• Benzodiazepines and Z-Drugs

• Non-GABAergic Anxiolytics

• DORA’s, Melatonin, Etifoxine

• Adverse Effects

• Clinical Pearls

• Precise selection of anxiolytics, sedatives, and hypnotic agents in different scenarios (Real Case Scenarios)

SECTION III:

SPECIAL POPULATIONS AND CLINICAL CONTEXTS

Psychopharmacology in Children and Adolescents

• Developmental Considerations

• Safety, Efficacy, and Long-Term Outcomes

• Approach to each disorder in depth

Psychopharmacology in Geriatric Psychiatry

• Age-Related Pharmacokinetic Changes

• Co-morbid conditions and rational psychopharmacological approach

Psychopharmacology in Pregnancy and Lactation

• Bodily changes in pregnancy

• Teratogenicity and Perinatal Risk Assessment

• Clinical Decision-Making Frameworks

Substance Use Disorders

• Neurobiology of Addiction

• Trait-based approach to treatment of addiction

• Pharmacotherapy protocol for management of individual substance

Psychopharmacology in Medical and Neurological Illness

• Drug-Drug Interactions

• Neuropsychiatric Manifestations of Systemic Disease and their treatment

• Anti-Seizure Medication

• Drugs used in Parkinson’s Disease

• Treatment of Movement Disorder (Approach to Movement Disorder)

• Delirium: The Conundrum resolved

SECTION IV:

ADVERSE EFFECTS, SAFETY, AND MONITORING

• Adverse Drug Reactions in Psychopharmacology

• Metabolic, Cardiovascular, and Endocrine Effects

• Extrapyramidal Syndromes

• Pharmacovigilance and Therapeutic Drug Monitoring

• Clinical Laboratory Monitoring (Serum level monitoring)

References: 

• CTP 11 Ed

• Kaplan & Sadock 12th Ed

• Tasman Psychiatry 5th Ed

• APA Textbook of Psychopharmacology 6th Ed

• Stahl’s Psychopharmacology, 5th Ed

• Green’s Child & Adolescent Clinical Psychopharmacology

• Psychopharmacology: Drugs, The Brain & Behaviour

• The Wiley-Blackwell Handbook of Addiction Psychopharmacology by James MacKillop

• Drugs and Pregnancy by Brett Little

• Meyler’s side effects of Psychiatric Drugs

• The Clozapine and Lithium Handbook

• Articles: Nature, JAMA, MDPI, IJP, IJPM, CINP, etc.

Whether you’re a psychiatry resident, clinician, or mental health enthusiast, this series will help you understand the “why” behind psychopharmacological decisions—from neurotransmitters to neural networks.

FAQ:

• Both live and recorded sessions will be made available to you all

• Special guest lectures will be done by experts in their respective fields.

• Workbooks will be provided to you all.

• Those who have enrolled in FINAL STRIKE 1.0, 2.0, 3.0 don't need to buy this course, as it will be provided to you for free

• Doubt discussion will be held on regular intervals.